It found that GLP-1s reduced the risk of alcohol-related disorders in those with no history of substance use by 18% and of using cannabis (14%), cocaine (20%), nicotine (20%) and opioids (25%), compared with those on other sodium-glucose cotransporter-2 drugs also used to treat diabetes
Other weeks you gain a pound despite perfect adherence
The most commonly reported side effects are mild gastrointestinal symptoms such as nausea, bloating, and temporary changes in digestion particularly during dose escalation
This showed that Tirzepatide helps with both blood sugar control and weight loss better than a leading diabetes peptide
for personal use because these products purchased from other countries often have not been approved by the FDA for use and sale in the U.S." The agency describes a narrow enforcement-discretion pathway with conditions that rarely fit this situation: the product must be for a serious condition for which effective treatment may not be available domestically, there must be no commercialization or promotion of the product to U.S
Maintaining stable weight significantly reduces revision likelihood
